Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Moderna’s vaccine highly protective, data show

Recently released data confirm that Moderna’s coronavirus vaccine is highly protective, setting the stage for its emergency authorization this week by federal regulators and the...

| By Kelley Gipson

Thetis wins orphan designation for colitis therapy

Thetis Pharmaceuticals has received an FDA orphan drug designation for TP-317 as a small molecule, oral therapy for treatment of pediatric ulcerative colitis. “We are pleased...

| By Kelley Gipson

Connecticut Innovations continues investments

Connecticut Innovations, the state’s venture capital and lending arm, has made $7.8 million worth of equity investments in its first quarter of fiscal year 2021...

| By Kelley Gipson

AlloMek furthers treatment for neurofibromatosis

Federal regulators have deemed a Woodbridge biotechnology company’s tumor-fighting therapy an ‘orphan’ drug, making it eligible for financial incentives. AlloMek Therapeutics earned the FDA designation...

| By Kelley Gipson

InveniAI® and Kyowa Kirin extend collaboration

InveniAI® and Kyowa Kirin have expanded their collaboration agreement to harness the power of InveniAI’s AI-platform, AlphaMeld®, for novel target discovery. Through this expansion, Kyowa Kirin will...

| By Kelley Gipson

Alexion: New formulation of ULTOMIRIS® in Europe

Alexion Pharmaceuticals reports that the European Commission has approved the new 100 mg/mL intravenous formulation of ULTOMIRIS® (ravulizumab) for the treatment of two ultra-rare diseases:...

| By Kelley Gipson

SCSU’s BioPath helping to boost CT bioscience

BioPath – an SCSU-led partnership of industry, academic and government leaders — has announced several new programs designed to meet the workforce needs of Connecticut’s growing bioscience...

| By Kelley Gipson

Sema4 opens second state-of-the-art lab in CT

Sema4 has opened its second state-of-the-art clinical laboratory in Connecticut. The newly built 70,000 square foot facility in Stamford will be home to 300+ employees and...